<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:53:40Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4101104" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:4101104</identifier><datestamp>2014-07-18</datestamp><setSpec>jclinneuro</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Clin Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Clin Neurol</journal-id>
      <journal-id journal-id-type="publisher-id">JCN</journal-id>
      <journal-title-group>
        <journal-title>Journal of Clinical Neurology (Seoul, Korea)</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1738-6586</issn>
      <issn pub-type="epub">2005-5013</issn>
      <publisher>
        <publisher-name>Korean Neurological Association</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC4101104</article-id>
      <article-id pub-id-type="pmcid">PMC4101104</article-id>
      <article-id pub-id-type="pmc-uid">4101104</article-id>
      <article-id pub-id-type="pmid">25045380</article-id>
      <article-id pub-id-type="doi">10.3988/jcn.2014.10.3.257</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Mutation analysis of <italic>SPAST</italic>, <italic>ATL1</italic>, and <italic>REEP1</italic> in Korean Patients with Hereditary Spastic Paraplegia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Tae-Hyoung</given-names>
          </name>
          <xref ref-type="aff" rid="A1">a</xref>
          <xref ref-type="aff" rid="A2">b</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Lee</surname>
            <given-names>Jae-Hyeok</given-names>
          </name>
          <xref ref-type="aff" rid="A1">a</xref>
          <xref ref-type="aff" rid="A2">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Young-Eun</given-names>
          </name>
          <xref ref-type="aff" rid="A1">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shin</surname>
            <given-names>Jin-Hong</given-names>
          </name>
          <xref ref-type="aff" rid="A1">a</xref>
          <xref ref-type="aff" rid="A2">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nam</surname>
            <given-names>Tai-Seung</given-names>
          </name>
          <xref ref-type="aff" rid="A3">c</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Hyang-Sook</given-names>
          </name>
          <xref ref-type="aff" rid="A2">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jang</surname>
            <given-names>Ho-Jung</given-names>
          </name>
          <xref ref-type="aff" rid="A2">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Semenov</surname>
            <given-names>Artem</given-names>
          </name>
          <xref ref-type="aff" rid="A2">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Sang Jin</given-names>
          </name>
          <xref ref-type="aff" rid="A4">d</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Kim</surname>
            <given-names>Dae-Seong</given-names>
          </name>
          <xref ref-type="aff" rid="A1">a</xref>
          <xref ref-type="aff" rid="A2">b</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>a</label>Department of Neurology, Pusan National University School of Medicine, Yangsan, Korea.</aff>
      <aff id="A2"><label>b</label>Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea.</aff>
      <aff id="A3"><label>c</label>Department of Neurology, Chonnam National University Hospital, Gwangju, Korea.</aff>
      <aff id="A4"><label>d</label>Department of Neurology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.</aff>
      <author-notes>
        <corresp>
Correspondence: Jae-Hyeok Lee, MD, PhD. Department of Neurology, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, 20 Geumo-ro, Mulgeum-eup, Yangsan 626-770, Korea. Tel +82-55-360-2453, Fax +82-55-360-2152, <email>jhlee.neuro@pusan.ac.kr</email></corresp>
        <corresp>
Correspondence: Dae-Seong Kim, MD, PhD. Department of Neurology, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, 20 Geumo-ro, Mulgeum-eup, Yangsan 626-770, Korea. Tel +82-55-360-2450, Fax +82-55-360-2152, <email>dskim@pusan.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>7</month>
        <year>2014</year>
      </pub-date>
      <volume>10</volume>
      <issue>3</issue>
      <fpage>257</fpage>
      <lpage>261</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>6</month>
          <year>2013</year>
        </date>
        <date date-type="rev-recd">
          <day>16</day>
          <month>12</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2014 Korean Neurological Association</copyright-statement>
        <copyright-year>2014</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background and Purpose</title>
          <p>Hereditary spastic paraplegia (HSP) is a genetically heterogeneous group of neurodegenerative disorders that are characterized by progressive spasticity and weakness of the lower limbs. Mutations in the spastin gene (<italic>SPAST</italic>) are the most common causes of HSP, accounting for 40-67% of autosomal dominant HSP (AD-HSP) and 12-18% of sporadic cases. Mutations in the atlastin-1 gene (<italic>ATL1</italic>) and receptor expression-enhancing protein 1 gene (<italic>REEP1</italic>) are the second and third most common causes of AD-HSP, respectively.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Direct sequence analysis was used to screen mutations in <italic>SPAST</italic>, <italic>ATL1</italic>, and <italic>REEP1</italic> in 27 unrelated Korean patients with pure and complicated HSP. Multiplex ligation-dependent probe amplification was also performed to detect copy-number variations of the three genes.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Ten different <italic>SPAST</italic> mutations were identified in 11 probands, of which the following 6 were novel: c.760A&gt;T, c.131C&gt;A, c.1351_1353delAGA, c.376_377dupTA, c.1114A&gt;G, and c.1372A&gt;C. Most patients with SPAST mutations had AD-HSP (10/11, 91%), and the frequency of SPAST mutations accounted for 66.7% (10/15) of the AD-HSP patients. No significant correlation was found between the presence of the SPAST mutation and any of the various clinical parameters of pure HSP. No <italic>ATL1</italic> and <italic>REEP1</italic> mutations were detected.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>We conclude that <italic>SPAST</italic> mutations are responsible for most Korean cases of genetically confirmed AD-HSP. Our observation of the absence of <italic>ATL1</italic> and <italic>REEP1</italic> mutations needs to be confirmed in larger series.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>hereditary spastic paraplegia</kwd>
        <kwd>
          <italic>SPAST</italic>
        </kwd>
        <kwd>
          <italic>ATL1</italic>
        </kwd>
        <kwd>
          <italic>REEP1</italic>
        </kwd>
        <kwd>Korea</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source country="KR">Pusan National University Yangsan Hospital</funding-source>
          <award-id>30-2012-011</award-id>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Hereditary spastic paraplegia (HSP) is a genetically heterogeneous group of neurodegenerative disorders that are characterized by progressive spasticity and weakness of the lower limbs.<xref rid="B1" ref-type="bibr">1</xref> Clinically, HSP can be classified as either "pure" or "complicated" depending on the presence of additional features such as ataxia, extrapyramidal signs, severe amyotrophy, peripheral neuropathy, optic atrophy, pigmentary retinopathy, mental retardation, dementia, and epilepsy.<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref></p>
      <p>Hereditary spastic paraplegia can be inherited as autosomal dominant (AD, AD-HSP), autosomal recessive, or an X-linked trait, and at least 52 loci have been mapped and 31 genes identified to date.<xref rid="B3" ref-type="bibr">3</xref> Mutations in the spastin gene (<italic>SPAST</italic>, SPG4) are the most common causes of HSP, accounting for up to 40-67% of AD-HSP cases and 12-18% of sporadic cases.<xref rid="B4" ref-type="bibr">4</xref>,<xref rid="B5" ref-type="bibr">5</xref>,<xref rid="B6" ref-type="bibr">6</xref>,<xref rid="B7" ref-type="bibr">7</xref> Mutations in the atlastin-1 gene (<italic>ATL1</italic>, SPG3A) and receptor expression-enhancing protein 1 gene (<italic>REEP1</italic>, SPG31) are the second and the third most common causes of AD-HSP, respectively.<xref rid="B1" ref-type="bibr">1</xref> More than half of all clinically diagnosed AD-HSP cases result from mutations in these three genes.<xref rid="B8" ref-type="bibr">8</xref> Therefore, mutation analysis of these genes will allow more-focused and cost-effective investigations of potential cases of HSP.</p>
      <p>The frequency of SPG4 is higher and the incidence of SPG3A is lower in Koreans than in other ethnic groups,<xref rid="B9" ref-type="bibr">9</xref>,<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B11" ref-type="bibr">11</xref>,<xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B13" ref-type="bibr">13</xref> which might be attributable to an ethnic difference in the genetic background of Korean patients with HSP. However, this needs to be confirmed in a larger series. No previous study has performed mutation screening of <italic>REEP1</italic> in Korean patients with HSP. The present study performed mutation analysis of <italic>SPAST</italic>, <italic>ATL1</italic>, and <italic>REEP1</italic> in 27 unrelated Korean patients with pure and complicated HSP in order to assess the role of these three genes in the occurrence of HSP in a Korean population.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>In total, 27 unrelated Korean probands with HSP were included in this study. All of these patients were evaluated neurologically and genetically after giving informed consent. This study was reviewed and approved by the Institutional Review Board of Pusan National University Yangsan Hospital. HSP was diagnosed by qualified neurologists on the basis of Harding's criteria.<xref rid="B14" ref-type="bibr">14</xref> Patients with other neurological conditions were excluded based on the clinical, radiological, and biochemical findings.</p>
      <p>Clinical parameters included age at onset, family history, and the presence of hyperreflexia, spasticity, weakness, and sensory abnormalities. Additional neurological signs that are suggestive of complicated cases, as mentioned above, were also described. Disability stage was assessed on the 5-point scale described by Fonknechten et al.<xref rid="B15" ref-type="bibr">15</xref></p>
      <p>Direct sequence analyses of whole coding regions of <italic>SPAST</italic>, <italic>ATL1</italic>, and <italic>REEP1</italic> were performed in order to identify mutations. Sequence-specific primer pairs covering the entire coding region of all three genes were used, as described elsewhere<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B17" ref-type="bibr">17</xref>,<xref rid="B18" ref-type="bibr">18</xref> with minor modifications (available upon request). Polymerase chain reaction (PCR) was performed in a Gene Atlas Thermal Cycler (ASTEC, Seoul, Korea). PCR-amplified products were separated and purified using 2% agarose gels and SolGent Agarose Gel Extraction Kits (SolGent, Daejeon, Korea), cycle-sequenced with PCR primers using the BigDye Terminator Sequencing Kit (Applied Biosystems, Foster, CA, USA), and electrophoresed using an ABI PRISM 3730XL DNA analyzer (Applied Biosystems, Foster, CA, USA).</p>
      <p>To confirm the pathogenicity of novel mutations identified in the sequence analysis, and to differentiate them from benign polymorphisms, PCR and restriction fragment length polymorphism (PCR-RFLP) analysis were performed using DNA from the included patients and 100 normal controls. Multiple sequence alignment of spastin orthologs was also conducted to evaluate two novel missense mutations and a novel in-frame deletion mutation for evolutionary conserved residues in the protein. Genomic and mRNA reference sequences of the three genes (<italic>SPAST</italic>: NG_008730.1, NM_014946.3; <italic>ATL1</italic>: NG_009028.1, NM_015915.4; and <italic>REEP1</italic>: NG_013037.1, NM_001164730.1) were used to describe the sequence variants.</p>
      <p>Among patients in whom direct sequencing analysis did not identify mutations, multiplex ligation-dependent probe amplification (MLPA) was performed to detect copy-number variations of the three genes. MLPA reactions were performed according to the manufacturer's protocol using MLPA kit P165 (<italic>SPAST</italic>, <italic>ATL1</italic>) and P213 (<italic>REEP1</italic>) from MRC-Holland (Amsterdam, The Netherlands).</p>
      <p>Statistical significance was assessed using nonparametric tests (the Mann-Whitney U test and Fisher's exact test) to establish any associations between the presence of a <italic>SPAST</italic> mutation and particular clinical parameters in patients with pure HSP. Spearman's rank correlation coefficient was used to measure the statistical significance between disease duration and disability score. All statistical analyses were performed using SPSS (version 18.0, SPSS Inc., Chicago, IL, USA).</p>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p>The patients' clinical data are given in <xref ref-type="supplementary-material" rid="S1">Supplementary Table 1</xref>. The age of the patients ranged from 14 to 64 years (meanÂ±SD=36.6Â±13.4 years); 16 patients were male and 11 were female. Fifteen of the 27 probands exhibited an AD inheritance pattern, and 9 appeared to be sporadic. The exact inheritance pattern could not be determined in three patients. The age at onset varied widely from 1 to 59 years (24.8Â±14.5 years). Nineteen and 8 patients were classified as pure and complicated HSP, respectively. The complicated forms included peripheral neuropathy on nerve conduction studies (<italic>n</italic>=2), mental retardation (<italic>n</italic>=3), epilepsy (<italic>n</italic>=1), cerebellar ataxia (<italic>n</italic>=1), saccadic pursuit (<italic>n</italic>=1), and dysarthria (<italic>n</italic>=6). Most of the complicated HSP patients had more than one additional feature.</p>
      <p>Ten different mutations of <italic>SPAST</italic>-comprising 4 missense, 4 nonsense, 1 in-frame deletion, and 1 frameshift mutations-were identified in 11 probands (<xref ref-type="table" rid="T1">Table 1</xref>, <xref ref-type="fig" rid="F1">Fig. 1</xref>). Six of these (c.760A&gt;T, c.131C&gt;A, c.1351_1353delAGA, c.376_377dupTA, c.1114A&gt;G, and c.1372A&gt;C) were novel, and the others (c.734C&gt;G, c.1496G&gt;A, c.1741C&gt;T, and c.1196C&gt;T) have been described previously.<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B20" ref-type="bibr">20</xref> Two novel missense mutations and one in-frame deletion mutation (c.1114A&gt;G, c.1372A&gt;C, and c.1351_1353delAGA) were located in the ATPases Associated with a wide variety of Activities (<italic>AAA</italic>) cassette domain. Two novel nonsense mutations and one frameshift mutation led to a premature termination codon, resulting in the production of a truncated protein. None of the mutation variants were found in 100 normal controls in PCR-RFLP analysis. No mutations in <italic>ATL1</italic> and <italic>REEP1</italic> were found, and no copy-number variants were detected among all three genes.</p>
      <p><italic>SPAST</italic> mutations were present in 66.7% (10/15) of the AD-HSP patients and 57.9% (11/19) of those with pure HSP. All of the <italic>SPAST</italic> mutations were associated with pure HSP. The clinical features of patients with pure HSP with <italic>SPAST</italic> mutations were compared to those without mutations (<xref ref-type="table" rid="T2">Table 2</xref>). In the <italic>SPAST</italic>-mutation-positive group, although most patients (90.9%, 10/11) had an AD inheritance pattern, the correlation was not statistically significant (<italic>p</italic>=0.111). Furthermore, various clinical parameters did not differ significantly between the <italic>SPAST</italic>-mutation-positive and -negative groups, and there was no significant correlation between disease duration and disability stage (Spearman's rho=0.239, <italic>p</italic>=0.324).</p>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>This study identified <italic>SPAST</italic> mutations in ten AD-HSP patients and one sporadic HSP patient among 27 unrelated pure and complicated HSP probands. Six of these mutations have not been described previously. The frequency of <italic>SPAST</italic> mutations in our AD-HSP patients (66.7%) is higher than those reported previously (range, 18-42%).<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>,<xref rid="B23" ref-type="bibr">23</xref> Park et al.<xref rid="B7" ref-type="bibr">7</xref> also reported a similar frequency of SPAST mutations in Korean patients with uncomplicated AD-HSP. However, they did not perform MLPA to identify exon deletions or duplications. According to previous studies, exon deletions of <italic>SPAST</italic> are not rare and have been found in 18% and 20% of the point-mutation-negative patients.<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B25" ref-type="bibr">25</xref> However, in our patients MLPA analysis of <italic>SPAST</italic> revealed no copy-number variants.</p>
      <p>Mutations of <italic>ATL1</italic> and <italic>REEP1</italic> are relatively common in other ethnic groups and have been variously identified in up to 9% and 6.5% of HSP patients.<xref rid="B13" ref-type="bibr">13</xref>,<xref rid="B26" ref-type="bibr">26</xref> Copy-number variations in <italic>ATL1</italic> and <italic>REEP1</italic> have also been reported.<xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref>,<xref rid="B29" ref-type="bibr">29</xref>,<xref rid="B30" ref-type="bibr">30</xref> However, we did not identify any pathogenic mutations in <italic>ATL1</italic> and <italic>REEP1</italic>. To date, only one Korean family with a missense mutation in <italic>ATL1</italic> has been reported. These results suggest that <italic>SPAST</italic> mutations are responsible for most cases of genetically confirmed AD-HSP in Korean patients. The relatively high rate of <italic>SPAST</italic> mutations and the lower incidence of <italic>ATL1</italic> and <italic>REEP1</italic> mutations among Korean HSP patients imply the existence of ethnic differences in the subtype of HSP. However, our observation of the absence of <italic>ATL1</italic> and <italic>REEP1</italic> mutations needs to be confirmed in larger series.</p>
      <p>Previous studies have demonstrated that most <italic>SPAST</italic> mutations are located in the <italic>AAA</italic> cassette domain, regardless of ethnicity.<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B21" ref-type="bibr">21</xref>,<xref rid="B22" ref-type="bibr">22</xref>,<xref rid="B23" ref-type="bibr">23</xref>,<xref rid="B31" ref-type="bibr">31</xref>,<xref rid="B32" ref-type="bibr">32</xref> Six of the causative mutations identified in this study are located in the <italic>AAA</italic> cassette domain. It is remarkable that three of the nonsense mutations and the single frameshift mutation in our patients were outside of this domain. All of these mutations are predicted to affect the <italic>AAA</italic> cassette domain indirectly. Nonsense and frameshift mutations are expected to cause premature truncation before and within the <italic>AAA</italic> cassette domain, thereby producing dysfunctional spastin.</p>
      <p>Mutations in <italic>SPAST</italic>, <italic>ATL1</italic>, and <italic>REEP1</italic> are predominantly associated with pure forms of AD-HSP.<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref> However, some of them may have other neurologic deficits seen in complicated HSP.<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref> They can also appear sporadically due to low penetrance, de-novo mutations, premature death of transmitting parents, or underrecognition of family history.<xref rid="B2" ref-type="bibr">2</xref> All of the <italic>SPAST</italic> mutations in our patients were associated with pure HSP. Most patients with <italic>SPAST</italic> mutations belonged to AD-HSP. The low incidence of <italic>SPAST</italic> mutations in the sporadic cases is consistent with the findings of previous studies.<xref rid="B19" ref-type="bibr">19</xref>,<xref rid="B21" ref-type="bibr">21</xref> Among various clinical parameters of pure HSP, no significant correlation was found with the presence of a <italic>SPAST</italic> mutation in this study. Previous studies have found the onset age to be lower in <italic>SPAST</italic>-mutation-negative groups,<xref rid="B32" ref-type="bibr">32</xref>,<xref rid="B33" ref-type="bibr">33</xref> and another study found that the disease progression was faster in patients with late-onset <italic>SPAST</italic> HSP than in those with early-onset HSP.<xref rid="B15" ref-type="bibr">15</xref> In addition, wheelchair use and abnormal vibration sense in the lower limbs were more common in a <italic>SPAST</italic>-mutation-positive group.<xref rid="B34" ref-type="bibr">34</xref> Further studies with larger numbers of patients are needed to elucidate the relationship between <italic>SPAST</italic> mutations and clinical phenotypes of Korean patients with HSP.</p>
      <p>In conclusion, we report herein a mutational analysis of <italic>SPAST</italic>, <italic>ATL</italic>, and <italic>REEP1</italic> in Korean patients with HSP. <italic>SPAST</italic> mutations were the found in most of the genetically confirmed AD-HSP patients. The findings of this study highlight the importance of <italic>SPAST</italic> mutation screening among Korean patients.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>This study was supported by Research Institute for Convergence of BioMedical Science and Technology Grant (30-2012-011), Pusan National University Yangsan Hospital.</p>
    </ack>
    <fn-group>
      <fn fn-type="conflict">
        <p>The authors have no financial conflicts of interest.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salinas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Proukakis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Crosby</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Warner</surname>
              <given-names>TT</given-names>
            </name>
          </person-group>
          <article-title>Hereditary spastic paraplegia: clinical features and pathogenetic mechanisms</article-title>
          <source>Lancet Neurol</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>1127</fpage>
          <lpage>1138</lpage>
          <pub-id pub-id-type="pmid">19007737</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Depienne</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Stevanin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Brice</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Durr</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Hereditary spastic paraplegias: an update</article-title>
          <source>Curr Opin Neurol</source>
          <year>2007</year>
          <volume>20</volume>
          <fpage>674</fpage>
          <lpage>680</lpage>
          <pub-id pub-id-type="pmid">17992088</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finsterer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>LÃ¶scher</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Quasthoff</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wanschitz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Auer-Grumbach</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stevanin</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance</article-title>
          <source>J Neurol Sci</source>
          <year>2012</year>
          <volume>318</volume>
          <fpage>1</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="pmid">22554690</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fink</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Hereditary spastic paraplegia</article-title>
          <source>Curr Neurol Neurosci Rep</source>
          <year>2006</year>
          <volume>6</volume>
          <fpage>65</fpage>
          <lpage>76</lpage>
          <pub-id pub-id-type="pmid">16469273</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Depienne</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tallaksen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lephay</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Bricka</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Poea-Guyon</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fontaine</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases</article-title>
          <source>J Med Genet</source>
          <year>2006</year>
          <volume>43</volume>
          <fpage>259</fpage>
          <lpage>265</lpage>
          <pub-id pub-id-type="pmid">16055926</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crippa</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Panzeri</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Martinuzzi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Arnoldi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Redaelli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Tonelli</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Eight novel mutations is SPG4 in a large sample of patients with hereditary spastic paraplegia</article-title>
          <source>Arch Neurol</source>
          <year>2006</year>
          <volume>63</volume>
          <fpage>750</fpage>
          <lpage>755</lpage>
          <pub-id pub-id-type="pmid">16682546</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Ki</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>BJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutation analysis of SPG4 and SPG3A genes and its implication in molecular diagnosis of Korean patients with hereditary spastic paraplegia</article-title>
          <source>Arch Neurol</source>
          <year>2005</year>
          <volume>62</volume>
          <fpage>1118</fpage>
          <lpage>1121</lpage>
          <pub-id pub-id-type="pmid">16009769</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McCorquodale</surname>
              <given-names>DS</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Ozomaro</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Montenegro</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kushman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Citrigno</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutation screening of spastin, atlastin, and REEP1 in hereditary spastic paraplegia</article-title>
          <source>Clin Genet</source>
          <year>2011</year>
          <volume>79</volume>
          <fpage>523</fpage>
          <lpage>530</lpage>
          <pub-id pub-id-type="pmid">20718791</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Cha</surname>
              <given-names>JI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel splicing mutation (c.870+3A&gt;G) in SPG4 in a Korean family with hereditary spastic paraplegia</article-title>
          <source>J Neurol Sci</source>
          <year>2010</year>
          <volume>290</volume>
          <fpage>186</fpage>
          <lpage>189</lpage>
          <pub-id pub-id-type="pmid">19939411</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yi</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Yoo</surname>
              <given-names>HW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Autosomal dominant hereditary spastic paraplegia relavant with a novel Thr369Pro mutation in SPAST gene</article-title>
          <source>J Korean Neurol Assoc</source>
          <year>2011</year>
          <volume>29</volume>
          <fpage>365</fpage>
          <lpage>367</lpage>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kwon</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Ki</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
          <article-title>Clinical and genetic analysis of a Korean family with hereditary spastic paraplegia type 3</article-title>
          <source>Ann Clin Lab Sci</source>
          <year>2010</year>
          <volume>40</volume>
          <fpage>375</fpage>
          <lpage>379</lpage>
          <pub-id pub-id-type="pmid">20947813</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hazan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fonknechten</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mavel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Paternotte</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Samson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Artiguenave</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia</article-title>
          <source>Nat Genet</source>
          <year>1999</year>
          <volume>23</volume>
          <fpage>296</fpage>
          <lpage>303</lpage>
          <pub-id pub-id-type="pmid">10610178</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Alvarado</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rainier</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lemons</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hedera</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Weber</surname>
              <given-names>CH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia</article-title>
          <source>Nat Genet</source>
          <year>2001</year>
          <volume>29</volume>
          <fpage>326</fpage>
          <lpage>331</lpage>
          <pub-id pub-id-type="pmid">11685207</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harding</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
          <article-title>Classification of the hereditary ataxias and paraplegias</article-title>
          <source>Lancet</source>
          <year>1983</year>
          <volume>1</volume>
          <fpage>1151</fpage>
          <lpage>1155</lpage>
          <pub-id pub-id-type="pmid">6133167</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fonknechten</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mavel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Byrne</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Davoine</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Cruaud</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>BÃ¶nsch</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia</article-title>
          <source>Hum Mol Genet</source>
          <year>2000</year>
          <volume>9</volume>
          <fpage>637</fpage>
          <lpage>644</lpage>
          <pub-id pub-id-type="pmid">10699187</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lindsey</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Lusher</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>McDermott</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Reid</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rubinsztein</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
          <article-title>Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis</article-title>
          <source>J Med Genet</source>
          <year>2000</year>
          <volume>37</volume>
          <fpage>759</fpage>
          <lpage>765</lpage>
          <pub-id pub-id-type="pmid">11015453</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guelly</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Leonardis</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>PapiÄ</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zidar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>SchabhÃ¼ttl</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Targeted high-throughput sequencing identifies mutations in atlastin-1 as a cause of hereditary sensory neuropathy type 1</article-title>
          <source>Am J Hum Genet</source>
          <year>2011</year>
          <volume>88</volume>
          <fpage>99</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="pmid">21194679</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Du</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>YG</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Receptor expression-enhancing protein 1 gene (SPG31) mutations are rare in Chinese Han patients with hereditary spastic paraplegia</article-title>
          <source>Chin Med J (Engl)</source>
          <year>2009</year>
          <volume>122</volume>
          <fpage>2064</fpage>
          <lpage>2066</lpage>
          <pub-id pub-id-type="pmid">19781397</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patrono</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Scarano</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Cricchi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Melone</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Chiriaco</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Napolitano</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Autosomal dominant hereditary spastic paraplegia: DHPLC-based mutation analysis of SPG4 reveals eleven novel mutations</article-title>
          <source>Hum Mutat</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>506</fpage>
          <pub-id pub-id-type="pmid">15841487</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meijer</surname>
              <given-names>IA</given-names>
            </name>
            <name>
              <surname>Hand</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Cossette</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Figlewicz</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Rouleau</surname>
              <given-names>GA</given-names>
            </name>
          </person-group>
          <article-title>Spectrum of SPG4 mutations in a large collection of North American families with hereditary spastic paraplegia</article-title>
          <source>Arch Neurol</source>
          <year>2002</year>
          <volume>59</volume>
          <fpage>281</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="pmid">11843700</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sauter</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Miterski</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Klimpe</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>BÃ¶nsch</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>SchÃ¶ls</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Visbeck</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia</article-title>
          <source>Hum Mutat</source>
          <year>2002</year>
          <volume>20</volume>
          <fpage>127</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="pmid">12124993</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yabe</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Sasaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tashiro</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsuura</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takegami</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Satoh</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Spastin gene mutation in Japanese with hereditary spastic paraplegia</article-title>
          <source>J Med Genet</source>
          <year>2002</year>
          <volume>39</volume>
          <fpage>e46</fpage>
          <pub-id pub-id-type="pmid">12161613</pub-id>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Three novel mutations of the spastin gene in Chinese patients with hereditary spastic paraplegia</article-title>
          <source>Arch Neurol</source>
          <year>2004</year>
          <volume>61</volume>
          <fpage>49</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="pmid">14732620</pub-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beetz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nygren</surname>
              <given-names>AO</given-names>
            </name>
            <name>
              <surname>Schickel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Auer-Grumbach</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>BÃ¼rk</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Heide</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia</article-title>
          <source>Neurology</source>
          <year>2006</year>
          <volume>67</volume>
          <fpage>1926</fpage>
          <lpage>1930</lpage>
          <pub-id pub-id-type="pmid">17035675</pub-id>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Depienne</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fedirko</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Forlani</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cazeneuve</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>RibaÃ¯</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Feki</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Exon deletions of SPG4 are a frequenct cause of hereditary spastic paraplegia</article-title>
          <source>J Med Genet</source>
          <year>2007</year>
          <volume>44</volume>
          <fpage>281</fpage>
          <lpage>284</lpage>
          <pub-id pub-id-type="pmid">17098887</pub-id>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>ZÃ¼chner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tran-Viet</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Nance</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Gaskell</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Vance</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31</article-title>
          <source>Am J Hum Genet</source>
          <year>2006</year>
          <volume>79</volume>
          <fpage>365</fpage>
          <lpage>369</lpage>
          <pub-id pub-id-type="pmid">16826527</pub-id>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beetz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>SchÃ¼le</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Deconinck</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tran-Viet</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kremer</surname>
              <given-names>BP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31</article-title>
          <source>Brain</source>
          <year>2008</year>
          <volume>131</volume>
          <issue>Pt 4</issue>
          <fpage>1078</fpage>
          <lpage>1086</lpage>
          <pub-id pub-id-type="pmid">18321925</pub-id>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Battini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fogli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Borghetti</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Michelucci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Perazza</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Baldinotti</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical and genetic findings in a series of Italian children with pure hereditary spastic paraplegia</article-title>
          <source>Eur J Neurol</source>
          <year>2011</year>
          <volume>18</volume>
          <fpage>150</fpage>
          <lpage>157</lpage>
          <pub-id pub-id-type="pmid">20550563</pub-id>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goizet</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Depienne</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Benard</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Boukhris</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mundwiller</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>SolÃ©</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>REEP1 mutations in SPG31: frequency, mutational spectrum, and potential association with mitochondrial morpho-functional dysfunction</article-title>
          <source>Hum Mutat</source>
          <year>2011</year>
          <volume>32</volume>
          <fpage>1118</fpage>
          <lpage>1127</lpage>
          <pub-id pub-id-type="pmid">21618648</pub-id>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sulek</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Elert</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rajkiewicz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zdzienicka</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Stepniak</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Krysa</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Screening for the hereditary spastic paraplegias SPG4 and SPG3A with the multiplex ligation-dependent probe amplification technique in a large population of affected individuals</article-title>
          <source>Neurol Sci</source>
          <year>2013</year>
          <volume>34</volume>
          <fpage>239</fpage>
          <lpage>242</lpage>
          <pub-id pub-id-type="pmid">22203332</pub-id>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Bot</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>van den Elzen</surname>
              <given-names>RT</given-names>
            </name>
            <name>
              <surname>Mensenkamp</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Schelhaas</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Willemsen</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Knoers</surname>
              <given-names>NV</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2010</year>
          <volume>81</volume>
          <fpage>1073</fpage>
          <lpage>1078</lpage>
          <pub-id pub-id-type="pmid">20562464</pub-id>
        </element-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erichsen</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Inderhaug</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mattingsdal</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Eiklid</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tallaksen</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Seven novel mutations and four exon deletions in a collection of Norwegian patients with SPG4 hereditary spastic paraplegia</article-title>
          <source>Eur J Neurol</source>
          <year>2007</year>
          <volume>14</volume>
          <fpage>809</fpage>
          <lpage>814</lpage>
          <pub-id pub-id-type="pmid">17594340</pub-id>
        </element-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Magariello</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Muglia</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Patitucci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ungaro</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mazzei</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gabriele</surname>
              <given-names>AL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutation analysis of the SPG4 gene in Italian patients with pure and complicated forms of spastic paraplegia</article-title>
          <source>J Neurol Sci</source>
          <year>2010</year>
          <volume>288</volume>
          <fpage>96</fpage>
          <lpage>100</lpage>
          <pub-id pub-id-type="pmid">19875132</pub-id>
        </element-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McMonagle</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Byrne</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Fitzgerald</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Parfrey</surname>
              <given-names>NA</given-names>
            </name>
            <name>
              <surname>Hutchinson</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Phenotype of AD-HSP due to mutations in the SPAST gene: comparison with AD-HSP without mutations</article-title>
          <source>Neurology</source>
          <year>2000</year>
          <volume>55</volume>
          <fpage>1794</fpage>
          <lpage>1800</lpage>
          <pub-id pub-id-type="pmid">11134375</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="S1">
        <caption>
          <title>Supplementary Table 1</title>
          <p>Clinical data of HSP patients</p>
        </caption>
        <media mimetype="application" mime-subtype="pdf" xlink:href="jcn-10-257-s001.pdf" orientation="portrait" id="d35e2293" position="anchor"/>
      </supplementary-material>
    </sec>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Organization of spastin and location of <italic>SPAST</italic> mutations identified in Korean HSP patients. <sup>*</sup>Nonsense mutations. AAA: ATPases Associated with a wide variety of Activities, HD: hydrophobic domain, HSP: hereditary spastic paraplegia, MIT: microtubule interacting and trafficking domain, MTBD: microtubule binding domain.</p>
      </caption>
      <graphic xlink:href="jcn-10-257-g001"/>
    </fig>
    <table-wrap id="T1" orientation="portrait" position="float">
      <label>Table 1</label>
      <caption>
        <p>SPG4 mutations identified in the study</p>
      </caption>
      <graphic xlink:href="jcn-10-257-i001"/>
      <table-wrap-foot>
        <fn>
          <p><sup>*</sup>Nonsense mutations.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="T2" orientation="portrait" position="float">
      <label>Table 2</label>
      <caption>
        <p>Comparison of clinical features between pure HSP groups with and without <italic>SPAST</italic> mutations</p>
      </caption>
      <graphic xlink:href="jcn-10-257-i002"/>
      <table-wrap-foot>
        <fn>
          <p>Statistical significance test was done by Mann-Whitney U test and Fisher's exact test.</p>
          <p>AD: autosomal dominant, HSP: hereditary spastic paraplegia.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>

</metadata></record></GetRecord></OAI-PMH>